Reckitt Benckiser Group plc (LON:RKT - Get Free Report) declared a dividend on Thursday, March 6th, DividendData.Co.Uk reports. Shareholders of record on Thursday, April 10th will be paid a dividend of GBX 121.70 ($1.59) per share on Thursday, May 29th. This represents a dividend yield of 2.38%. The ex-dividend date is Thursday, April 10th. This is a 51.4% increase from Reckitt Benckiser Group's previous dividend of $80.40. The official announcement can be seen at this link.
Reckitt Benckiser Group Stock Up 0.1 %
Shares of RKT stock traded up GBX 6 ($0.08) during trading hours on Friday, reaching GBX 4,766 ($62.36). The company had a trading volume of 2,531,736 shares, compared to its average volume of 5,676,491. The company has a market capitalization of £32.52 billion, a P/E ratio of 21.81, a price-to-earnings-growth ratio of 1.10 and a beta of 0.09. The company has a debt-to-equity ratio of 110.26, a quick ratio of 0.46 and a current ratio of 0.69. Reckitt Benckiser Group has a twelve month low of GBX 4,034 ($52.78) and a twelve month high of GBX 5,418 ($70.89). The stock's fifty day simple moving average is GBX 5,175.39 and its 200 day simple moving average is GBX 4,958.83.
Reckitt Benckiser Group (LON:RKT - Get Free Report) last released its quarterly earnings results on Thursday, March 6th. The company reported GBX 349.70 ($4.58) earnings per share for the quarter. Reckitt Benckiser Group had a return on equity of 18.70% and a net margin of 10.78%. As a group, sell-side analysts expect that Reckitt Benckiser Group will post 331.2110727 earnings per share for the current fiscal year.
Insider Activity at Reckitt Benckiser Group
In related news, insider Kris Licht sold 3,799 shares of the stock in a transaction dated Friday, March 21st. The stock was sold at an average price of GBX 5,177 ($67.74), for a total value of £196,674.23 ($257,325.96). Company insiders own 0.05% of the company's stock.
About Reckitt Benckiser Group
(
Get Free Report)
Reckitt Benckiser Group plc manufactures and sells health, hygiene, and nutrition products worldwide. It offers acne treatment creams, facial washes, and cleansing pads; germ protection products; condoms; heartburn and indigestion solutions; joints health products; chest congestion, cough, and sinus remedies; brain health products; migraine-headaches and rheumatic pain products; sore throat medications; and hair removal products under the Airborne, Clearasil, Dettol, Durex, Gaviscon, Move Free, Neuriva, Nurofen, Mucinex, Strepsils, and Veet brands.
Further Reading
Before you consider Reckitt Benckiser Group, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Reckitt Benckiser Group wasn't on the list.
While Reckitt Benckiser Group currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Learn how options trading can help you navigate market volatility, manage risk, and maximize returns with MarketBeat's "Unlock the Potential in Options Trading." Click the link below to have this special report delivered to your inbox.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
